Otonomy Inc.

Otonomy Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.66
Market Cap
$78.55 M
Shares Outstanding
30.69 M
Public Float
25.01 M

Profile

Address
4796 Executive Drive
San Diego California 92121
United States
Employees -
Website http://www.otonomy.com
Updated 07/08/2019
Otonomy, Inc. is a biopharmaceutical company, which engages in the research, development, and manufacture of therapeutics for otology. The firm's portfolio includes therapeutics for diseases and disorders of the ear such as Ménière's disease, tinnitus, synaptopathy hearing loss, cisplatin-induced loss, severe hearing loss, TTP surgery, and acute otitis externa. It operates under the Otiprio brand.

Financials

View All
Created with Highcharts 5.0.14Otonomy Inc.Net Income. Fiscal year is January-December. All values USD Thousands.19 55919 55942 87742 87761 66861 668110 583110 58390 13090 13050 36850 368201320142015201620172018025k50k75k100k125k
Created with Highcharts 5.0.14Otonomy Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.0000006836831 2361 2367457452013201420152016201720180250500750100012501500

Jay B. Lichter
Chairman
David A. Weber
President, Chief Executive Officer & Director